{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:10:43Z","timestamp":1792141843631,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30-026877"],"award-info":[{"award-number":["P30-026877"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajoc.2024.102124","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T16:44:57Z","timestamp":1721666697000},"page":"102124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Siponimod-associated cystoid macular edema without known risk factors"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6747-0961","authenticated-orcid":false,"given":"Min Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-2719","authenticated-orcid":false,"given":"Anas","family":"Alkhabaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7958-291X","authenticated-orcid":false,"given":"Yaping Joyce","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2024.102124_bib1","article-title":"Cystoid macular edema: a rare adverse reaction to rituximab","volume":"16","author":"Machado","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102124_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/OPTH.S4033","article-title":"Cystoid macular edema","volume":"2","author":"Rotsos","year":"2008","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajoc.2024.102124_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s40265-021-01528-8","article-title":"Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis","volume":"81","author":"Perez-Jeldres","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102124_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13643-021-01782-7","article-title":"Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature","volume":"10","author":"Munoz-Ortiz","year":"2021","journal-title":"Syst Rev"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102124_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/acn3.52017","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: a practical review","volume":"11","author":"Coyle","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102124_bib6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S1474-4422(13)70102-9","article-title":"Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study","volume":"12","author":"Selmaj","year":"2013","journal-title":"Lancet Neurol"},{"issue":"10127","key":"10.1016\/j.ajoc.2024.102124_bib7","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajoc.2024.102124_bib8","series-title":"Novartis. Mayzent (Siponimod) [package Insert]","year":"2019"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102124_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12883-023-03333-0","article-title":"Macular edema after siponimod treatment for multiple sclerosis: a case report and literature review","volume":"23","author":"Li","year":"2023","journal-title":"BMC Neurol"},{"issue":"11","key":"10.1016\/j.ajoc.2024.102124_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-251066","article-title":"Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema","volume":"15","author":"Foos","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102124_bib11","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/WNO.0000000000001788","article-title":"Siponimod-related bilateral macular edema: a transient and completely reversible disorder","volume":"44","author":"Miscioscia","year":"2024","journal-title":"J Neuro Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102124_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.nerep.2021.100031","article-title":"Siponimod associated macular edema in a patient with multiple sclerosis","volume":"1","author":"Rettler","year":"2021","journal-title":"Neuroimmunology Reports"},{"issue":"7","key":"10.1016\/j.ajoc.2024.102124_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40263-015-0261-z","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis","volume":"29","author":"Subei","year":"2015","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102124_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s42466-022-00219-3","article-title":"Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis","volume":"4","author":"Regner-Nelke","year":"2022","journal-title":"Neurol Res Pract"},{"issue":"7","key":"10.1016\/j.ajoc.2024.102124_bib15","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2012.12.040","article-title":"Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis","volume":"120","author":"Zarbin","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2024.102124_bib16","series-title":"Macular Edema Associated with Fingolimod","author":"Jain","year":"2012"},{"key":"10.1016\/j.ajoc.2024.102124_bib17","series-title":"Ophthalmic Screening Recommendation for New MS Drug","author":"Lee","year":"2011"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:38:06Z","timestamp":1737693486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":17,"alternative-id":["S2451993624001348"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102124","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Siponimod-associated cystoid macular edema without known risk factors","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102124"}}